Skip to main content

Meningococcal Conjugate Vaccine Dosage

Medically reviewed by Last updated on Jan 4, 2022.

Applies to the following strengths: polysaccharide tetanus toxoid group ACYW; group ACYW

Usual Adult Dose for Meningococcal Meningitis Prophylaxis

0.5 mL intramuscularly once

Usual Pediatric Dose for Meningococcal Meningitis Prophylaxis

2 years or older:
0.5 mL intramuscularly once.

Renal Dose Adjustments

Data not available

Liver Dose Adjustments

Data not available

Dose Adjustments


  • Booster doses of 0.5 mL, subcutaneously, may be given to patients at high risk for meningococcal disease.
  • The ACIP (Advisory Committee on Immunization Practices) has revaccination recommendations.



  • Severe allergic reaction (e.g. anaphylaxis) to any of the ingredients or to other CRM197-, diphtheria toxoid-, or meningococcal-containing vaccine

Safety and efficacy have not been established in patients younger than 2 years.
To report suspected adverse reactions, contact the Vaccine Adverse Event Reporting System (VAERS) at:

Consult WARNINGS section for additional precautions.


Data not available

Other Comments

Administration advice:

  • The deltoid is the preferred site.
  • Do not administer IV or IM.

Storage requirements:
  • Refrigerate; do not freeze.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.